Should You Buy Ascendis Pharma A/S (ASND)?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Ascendis Pharma A/S (ASND)
Market is closed
News
- First
- << Previous
- 51 - 60
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex.
13D Filing: OrbiMed Advisors and Ascendis Pharma A/S (ASND)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
Are Hedge Funds On To Something With Ascendis Pharma A/S (ASND) Bullishness?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash...
Ascendis Pharma (ASND): OrbiMed Advisors Adds More Shares
Samuel Isaly just cannot get enough of Ascendis Pharma A/S (NASDAQ:ASND).
OrbiMed Advisors Buys Some More Ascendis Pharma (ASND) Shares
Samuel Isaly's OrbiMed Advisors has stepped up its interest in Ascendis Pharma A/S (NASDAQ:ASND) as reported in a recently-amended filing with the Securities and Exchange Commission. OrbiMed's stake...
Hedge Funds Aren't Crazy About Ascendis Pharma A/S (ASND) Anymore
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly...
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman.
Jacob Gottlieb Adds To Position In Ascendis Pharma A/S (ASND); Armistice Capital Increases Stake In Demand Media Inc (DMD)
Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly increased its holding in the company recently...
Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company
Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working on a novel method of delivering new and existing...
- First
- << Previous
- 51 - 60
Billionaire Hedge Funds
